Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The ancestral origin of the critically endangered Quadricorna sheep as revealed by genome-wide analysis.
Senczuk G, Di Civita M, Rillo L, Macciocchi A, Occidente M, Saralli G, D'Onofrio V, Galli T, Persichilli C, Di Giovannantonio C, Pilla F, Matassino D. Senczuk G, et al. Among authors: macciocchi a. PLoS One. 2022 Oct 26;17(10):e0275989. doi: 10.1371/journal.pone.0275989. eCollection 2022. PLoS One. 2022. Retraction in: PLoS One. 2022 Dec 7;17(12):e0279019. doi: 10.1371/journal.pone.0279019. PMID: 36288337 Free PMC article. Retracted.
Retraction: The ancestral origin of the critically endangered Quadricorna sheep as revealed by genome-wide analysis.
Senczuk G, Di Civita M, Rillo L, Macciocchi A, Occidente M, Saralli G, D'Onofrio V, Galli T, Persichilli C, Di Giovannantonio C, Pilla F, Matassino D. Senczuk G, et al. Among authors: macciocchi a. PLoS One. 2022 Dec 7;17(12):e0279019. doi: 10.1371/journal.pone.0279019. eCollection 2022. PLoS One. 2022. PMID: 36476880 Free PMC article. No abstract available.
Minimally-Invasive Endoscopic-Assisted Sinus Augmentation.
Giovannetti F, Raponi I, Priore P, Macciocchi A, Barbera G, Valentini V. Giovannetti F, et al. Among authors: macciocchi a. J Craniofac Surg. 2019 Jun;30(4):e359-e362. doi: 10.1097/SCS.0000000000005365. J Craniofac Surg. 2019. PMID: 30817509
A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy.
Aapro MS, Grunberg SM, Manikhas GM, Olivares G, Suarez T, Tjulandin SA, Bertoli LF, Yunus F, Morrica B, Lordick F, Macciocchi A. Aapro MS, et al. Among authors: macciocchi a. Ann Oncol. 2006 Sep;17(9):1441-9. doi: 10.1093/annonc/mdl137. Epub 2006 Jun 9. Ann Oncol. 2006. PMID: 16766588 Free article. Clinical Trial.
Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist: results of a phase III, single-dose trial versus dolasetron.
Eisenberg P, Figueroa-Vadillo J, Zamora R, Charu V, Hajdenberg J, Cartmell A, Macciocchi A, Grunberg S; 99-04 Palonosetron Study Group. Eisenberg P, et al. Among authors: macciocchi a. Cancer. 2003 Dec 1;98(11):2473-82. doi: 10.1002/cncr.11817. Cancer. 2003. PMID: 14635083 Free article. Clinical Trial.
Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron.
Gralla R, Lichinitser M, Van Der Vegt S, Sleeboom H, Mezger J, Peschel C, Tonini G, Labianca R, Macciocchi A, Aapro M. Gralla R, et al. Among authors: macciocchi a. Ann Oncol. 2003 Oct;14(10):1570-7. doi: 10.1093/annonc/mdg417. Ann Oncol. 2003. PMID: 14504060 Free article. Clinical Trial.
24 results